Provided by Tiger Fintech (Singapore) Pte. Ltd.

HEC CJ PHARM

9.840
+0.1001.03%
Volume:1.51M
Turnover:14.75M
Market Cap:8.66B
PE:4.05
High:9.890
Open:9.700
Low:9.700
Close:9.740
Loading ...

Despite shrinking by HK$405m in the past week, YiChang HEC ChangJiang Pharmaceutical (HKG:1558) shareholders are still up 74% over 3 years

Simply Wall St.
·
03 Mar

Earnings Working Against YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Share Price

Simply Wall St.
·
24 Jan

Has YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Simply Wall St.
·
16 Dec 2024

BRIEF-Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee

Reuters
·
05 Dec 2024

YiChang HEC ChangJiang Pharmaceutical - Preparation for Filing With Listing Committee Reached an Advanced Stage

THOMSON REUTERS
·
05 Dec 2024

YiChang HEC ChangJiang Pharmaceutical (HKG:1558) delivers shareholders respectable 21% CAGR over 3 years, surging 6.7% in the last week alone

Simply Wall St.
·
18 Nov 2024

Yichang HEC Changjiang Pharmaceutical's Merger Offeror Agreed to License-out Product for $938 Million

MT Newswires Live
·
13 Nov 2024

BRIEF-YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement

Reuters
·
12 Nov 2024

YiChang HEC ChangJiang Pharmaceutical - Agreement to Develop and Commercialise Apl-18881 (Hec88473), a Fgf21 / Glp-1 Dual Receptor Agonist

THOMSON REUTERS
·
12 Nov 2024

YiChang HEC ChangJiang Pharmaceutical - Sunshine Lake Pharma to Enter Licensing Agreement With Apollo Therapeutics

THOMSON REUTERS
·
12 Nov 2024

Should You Be Adding YiChang HEC ChangJiang Pharmaceutical (HKG:1558) To Your Watchlist Today?

Simply Wall St.
·
20 Sep 2024